Cleveland Clinic Abu Dhabi, a Mubadala Company, is a world-class multispecialty hospital on Al Maryah Island in Abu Dhabi, UAE, and is scheduled to begin seeing patients in 2015.
The hospital was designed and developed by Abu Dhabi’s Mubadala Development Company and leading US-based hospital, Cleveland Clinic, to address a range of complex and critical care requirements unique to the Abu Dhabi population. Mubadala is helping to address the region’s most pressing healthcare needs through the creation of specialist healthcare facilities, building regional capability and stimulating the overall development of the sector.
A unique and unparalleled extension of US-based Cleveland Clinic’s model of care, Cleveland Clinic Abu Dhabi will provide direct access to the world’s best healthcare providers and Cleveland Clinic’s unique model of care in the UAE, reducing the need for patients to travel abroad for treatment.
Cleveland Clinic Abu Dhabi will have five Centers of Excellence, in the following Institutes: Heart & Vascular, Neurological, Digestive Disease, Eye and Respiratory & Critical Care. Other Institutes will include Surgical Subspecialties, Medical Subspecialties, Emergency Medicine, Anesthesiology, Pathology & Laboratory Medicine, Imaging, and Quality & Patient Safety. In all, more than 30 medical and surgical specialties will be represented at Cleveland Clinic Abu Dhabi.
Cleveland Clinic Abu Dhabi will be a 364 (expandable to 490) bed hospital, with five clinical floors, three diagnostic and treatment levels and 13 floors of critical and acute inpatient units. It will be a physician-led medical facility served by North American board certified (or equivalent) and Health Authority-Abu Dhabi licensed physicians. Patients will be treated in an unparalleled environment. The facilities at Cleveland Clinic Abu Dhabi will combine state-of-the-art amenities and world-class service standards.